Diadema Partners »

Amgen shares owned by Diadema Partners

Quarter-by-quarter ownership of Amgen (AMGN) shares owned by Diadema Partners from 13F filings

Historical chart of Diadema Partners investment in Amgen

Tip: Access up to 7 years of quarterly data

All positions including Amgen held by Diadema Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amgen by Diadema Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $41M 113k 362.12

More positions owned by Diadema Partners

Abivax Sa Sponsored Ads Call Option (ABVX)
Viking Therapeutics (VKTX)
Bristol Myers Squibb Put Option (BMY)
Amgen Call Option (AMGN)
United Therapeutics Corporation (UTHR)
Revolution Medicines (RVMD)
Uniqure Nv SHS Put Option (QURE)
Novartis Sponsored Adr Call Option (NVS)
Kodiak Sciences Call Option (KOD)
Capricor Therapeutics Com New Put Option (CAPR)
Cogent Biosciences (COGT)
Bridgebio Pharma Note 1.750% 3/0 (Principal)
Corcept Therapeutics Incorporated Call Option (CORT)
BioMarin Pharmaceutical (BMRN)
Kymera Therapeutics Call Option (KYMR)

View all positions for Diadema Partners

Top funds holding Amgen

BlackRock
Vanguard Capital Management
State Street Corporation
Capital World Investors
Invesco
Morgan Stanley
Geode Capital Management
Charles Schwab Investment Management
Sixth Street Partners Management Company
Vanguard Portfolio Management
Wells Fargo & Company
PRIMECAP Management Company
Capital Research Global Investors
Northern Trust
Norges Bank Investment Management

View all funds holding Amgen